Vincerx Pharma, Inc. (VINC) delivered a return of -76.91% over the past year. Since VINC does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in Vincerx Pharma, Inc. one year ago would be worth $2,309 today, representing a loss of $7,691.

Vincerx Pharma, Inc. (VINC) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For VINC, the total return equals the price-only return.

No, Vincerx Pharma, Inc. (VINC) underperformed the S&P 500 by 97.75 percentage points over the past year. VINC delivered a total return of -76.91%, compared to the S&P 500's 20.84%. This means a passive S&P 500 index fund outperformed VINC by 97.75pp during this period.

Vincerx Pharma, Inc. (VINC) experienced a maximum drawdown of -92.42% over the past year, declining from its peak on 2025-10-08 to its trough on 2025-10-30. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are Vincerx Pharma, Inc. (VINC)'s long-term returns with dividends reinvested. Over 10 years, the total return is -100.0% (-61.7% CAGR) — $10,000 would have grown to $1. Over 20 years: -100.0% total return (-38.1% CAGR) — $10,000 → $1. Over 30 years: -100.0% total return (-27.4% CAGR) — $10,000 → $1. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Vincerx Pharma, Inc.'s best calendar year was 2020 with a total return of 123.6%. Its worst year was 2025 with a total return of -99.7%. This range shows the volatility investors should expect — the difference between the best and worst year is 223.4 percentage points.